Introduction
The Indiana University Cyclotron Facility (IUCF) is a research facility that has been operating since 1975. It houses three research accelerators (a 205 MeV cyclotron, a 240 MeV synchrotron, and a 500 MeV synchrotron) and the requisite space to develop and carry out a broad program of fundamental and applied research. Research activities at IUCF include nuclear and accelerator physics, material science, radiation biology, and proton therapy.
IU is converting 12,000 fi? of research space associated with the 205 MeV cyclotron into a regional proton therapy center that will make use of the natural advantages of proton radiation for research in the treatment of patients. This center, the Midwest Proton Radiotherapy Institute (MPRI), will bring this new modality to within 300 miles of one-quarter of the US population'. Clinical trials aimed at evaluating the efficacy of new treatments, and research in the development and optimization of new treatments will be conducted at MPRI. MPRI will be a self-supporting radiation treatment facility with income derived fiom the fees charged for patient treatment and related ancillary activities2.
The performance requirements for MPRI are described in the Clinical Performance Requirements3. The conversion is being accomplished under the supervision of both the medical director, Allan Thornton, M.D. and the technical director, John Cameron, Ph.D., in consultation with the equity partner hospitals and a regional consortium of referral physicians. The design and construction are being executed primarily by the scientists, engineers, and technicians at IUCF. Figure 1 shows MPRI in detail. The conversion will result in three patient treatment rooms and an outpatient clinic. The first treatment room contains a fixed horizontal beam delivery system with two treatment lines: a Large Field Line for treating head and neck tumors, primarily, and and Eye Line for treating eye tumors. The second and third treatment rooms will each be equipped with a 3608 isocentric rotating gantry. The gantry makes it possible to treat tumors fiom any angle without having to move the patient, thereby allowing for maximum efficacy in avoiding critical organs, and efficiency in patient set-up and beam delivery4. Finally, an outpatient clinic has been constructed for patient care and st& support.
DOE Contribution
This grant was active from July 15,2000 to July 14,2002. IUCF/MPRI was awarded $1,873,000 for salaries for IUCF personnel to develop the first treatment room and its associated beam transport line, including an energy selection system. During the funding period the development included:
1. Construction and commissioning of the TO Achromat 2. Design, construction, and commissioning of the Trunk Line 
Trunk Line
The Trunk Line delivers the beam fiom the TO Achromat to the beam dump at the end of the line, providing a continuous beam of protons for any of the three treatment rooms to take when it is ready. The Trunk Line operates at a fixed energy of 205 MeV, which corresponds to a 27 crn proton range in water. To adjust the proton range for each treatment field, each treatment room has an associated energy degrader that is situated at the beginning of the Energy Selection (ES)
Line. The optics of the Trunk Line consists of three sections (Tl, T2, T3). Each section ends with a beam double focus, which corresponds to the ES Line degrader "location" projection onto the Trunk Line. Consequently, when beam is delivered to the corresponding treatment room, the double focus occurs at the degrader. The second and third sections of the Trunk Line have telescopic properties, i.e. they reproduce the beam optics and provide the same beam focus at the degrader locations for the second and third treatment rooms. 
Energy Selection Line
To allow for independent setup and operation, each treatment room has its own Energy Selection (ES) beam line' where the beam properties will be set for each treatment. Each ES line has a kicker dipole and Lambertson magnet pair that provides fast beam switching into that ES line. Each time the kicker is activated, the beam is kicked vertically up into the dipole field region of the Lambertson magnet where it is bent by 12' horizontally to the ES Line.
A variable thickness energy degrader in each ES Line sets the beam energy for a given treatment.
All ES Line magnets are laminated magnets to allow for reproducible energy changes.
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After the beam energy is degraded to the required treatment energy, the beam is trakported through two 63-degree bending magnets and 8 quadrupoles, optically configured into a double achromat, as shown in Figure 2 . The ES Line optics are designea to produce significant momentum dispersion between the dipoles, which allows momentum band cutting, while at the entrance to the treatment room (or gantry), momentum dispersion is completely canceled'. The 63-degree bending magnets also eliminate transmission of neutron radiation created by the degradation process. The detailed design specifications for the magnetic elements are described in the ES Line design reportg. 
Dose Delivery System for the Large Field Line
The Fixed Beam Dose Delivery System @IDS)'' oversees the application of the proton beam to the patient via either the Large Field Line or the Eye Line in Treatment Room One. Since these two treatment lines are installed in the same treatment room, they cannot operate simultaneously. Each line has its own nozzle to facilitate the dose delivery process. The proton beam will be directed into one nozzle or the other by means of a & 10 degree switch magnet, and its position will be measured with gas harps installed in each of the nozzles. The switch magnet and gas harps are part of the ES Line described above. The responsibilities of the DDS with respect to delivering the beam to a patient, starts beyond the gas harps. This is illustrated schematically in . Ihdiaha University DOE ER62966 0006042
The dose delivery process includes spreading, modulating, and collimating (shaping) the beam, monitoring the properties of the dose being delivered, and stopping the treatment when either a) the dose has been successfblly delivered, or b) the system detects a parameter that is out of tolerance.
A schematic illustration of the beam delivery nozzle for large field treatments is shown in Figure  4 . The large field nozzle contains the devices required to modify the incident proton beam to the required shape and size. This includes a scan magnet and passive scattering elements, a beam energy modulator (ridge filter), several anti-scatter collimators, several ionization chambers and a retractable snout system to mount the patient-specific apertures and compensators as close as possible to the patient. Parallel plate ionization chambers are the primary dose measuring devices while segmented ionization chambers are used to measure beam symmetry and flatness. System (mCS). The DDS control system has three separate control processes, as illustrated in Figure 5 . They are (1) to monitor the dose delivered to the patient, (2) to spread the beam using the either the scanning magnet or the passive scattering system and (3) to modify the beam shape and energy distribution using several patient and beam-specific devices such as ridge filters, apertures and compensators.
End of Beam
. . Ihdika University DOE ER62966 0006042 The dose monitoring function (upper trace in Figure 5 ) is facilitated by two electronic units called Dose Terminators @Ts) and manages the dose delivery process, which includes validating several beam parameters. The dose monitoring function involves three feedback loops to ensure that (1) the dose delivered to the patient does not exceed the prescribed dose, (2) the beam flatness and symmetry meet the specifications, and (3) the appropriate high voltages are applied to the ionization chambers.
The beam spreading function (lower trace in Figure 5 ) involves spreading the beam in two dimensions to cover the maximum lateral dimensions of the treatment target. Two methods will be employed to spread the beam. The first method will use two passive scatterers to spread the beam for field sizes up to a maximum diameter of 120 mm. A single control loop is required for passive scattering to verify the longitudinal position of the first scatterer, which is motorized. The second method actively spreads the beam using a scanning magnet that sweeps the beam in two dimensions across the treatment area. The scanning magnet will be employed at a later stage.
The beam modifying function (lower trace in Figure 5 ) involves shaping the beam according to the beams eye view of the target and modifying the energy distribution (energy modulation) to conform precisely to the treatment volume while maintaining other specified beam properties. The beam energy modulation is done by means of ridge filters. Modulating the beam energy in a predetermined manner allows for spreading out the Bragg peak by a desired length, creating a Spread Out Bragg Peak (SOBP). Beam shaping is achieved by means of patient-specific . Ihdiha University DOE ER62966 0006042 apertures and patient-specific range modifying compensators. Although all these are passive devices, a control loop is required to read the interlocks fiom each device to verify that the correct devices are installed in the proper places for a specific treatment field. 
Design of the

Conclusion
This grant funded engineering and technical staff who were designing, constructing, and commissioning the beam and dose delivery systems for the first treatment room for MPRI. During the funding period, the first three construction milestones were met, as shown in Table 2 below. As of this writing, the project is still on track to meet all of the milestones. This grant represented approximately 40% of the total salary expenditures for all MPRI development activities through 2002.
